- Home
- Companies
- canada saskatchewan
- genome analysis
Refine by
Genome Analysis Suppliers Near Canada Saskatchewan
37 companies found
based inMontpellier, FRANCE
SeqOne Genomics is a startup based in Montpellier in the South of France, founded in 2017. The company develops state-of-the-art genomics analysis tools for clinical applications in the fields of cancer and rare diseases. Its flagship product, ...
We offer a comprehensive solution for hereditary and rare disease data that detects both commonly accessible variants and relevant challenging variants such as mid-sized deletions, Alu elements and larger structural ...
based inNEW YORK (USA)
Our company is a globally operating service provider and one of the world leaders in the development and delivery of advanced drug therapies for rare diseases. We not only provide global customers with a wide range of services for rare disease ...
based inFremont, CALIFORNIA (USA)
Ultima Genomics is a pioneering company in the genomics sector, focusing on revolutionizing genomic sequencing through innovative technology and new sequencing architecture. The company's mission is to expand the scale of omics information, thereby ...
based inHuntsville, ALABAMA (USA)
Founded in 2009 at the Hudson Alpha Institute for Biotechnology, iRepertoire was the first company to develop and commercialize immune repertoire sequencing technology and ...
Allow us to prepare your samples for sequencing with our cell thawing, staining, sorting, plating and nucleic acid extraction options for bulk repertoire and single cell sequencing projects. We ensure efficient and cost-effective services from ...
based inLanghorne, PENNSYLVANIA (USA)
Syncro Medical takes quality very seriously. We’re software craftsmen – attention to quality is part of our culture and embedded in every aspect of how we deliver our services. Competition within the medical device industry continues to intensify. ...
based inAurora, COLORADO (USA)
Triopsy Medical, Inc. manufacturer of Cancer Diagnosis system. Our new Triopsy approach will create opportunity across three key market segments: medical device, pathology systems, and mapping systems for more accurate diagnosis. Our novel biopsy ...
based inLund, SWEDEN
Our mission is to make it easier to analyze the huge amounts of complex data that are generated by innovations in the fields of genetics and proteomics. We do this by providing powerful visualization-based bioinformatics data analysis tools for ...
Flexibility and expansion are cornerstones. Analyze data using an easy to use statistical model. Integrate and extend the analysis with Python based Templates for scripting. Add statistical methods through the Open API to R. Filter ...
based in, INDIA
inDNA Research Labs is an early stage big-data analytics healthcare startup that is at the forefront of trying to bring comprehensive genomic analysis to routine clinical care. Our goal is to democratize the use of genomics technologies by ...
based inPréverenges, SWITZERLAND
Founded in 2016 by a group of experienced engineers and bio-informaticians under the leadership of Claudio Alberti, our CTO, GenomSys is a Swiss company developing state-of-the-art technology and services for the efficient analysis and secure ...
GenomSys Variant Analyzer is a CE-marked platform natively operating on MPEG-G genomic data format that enables accurate variants identification, annotation, and interpretation (SNVs, indels, CNVs). Based on state-of-the-art pipelines and leveraging ...
based inVienna, AUSTRIA
Lexogen is a biotech company with unique proprietary expression profiling technologies that enable detailed analysis of the complete transcriptome as well as individual full length RNAs of interest. Lexogen was founded in 2007 with an investment by ...
The QuantSeq FWD Kit is a library preparation protocol designed to generate Illumina compatible libraries of sequences close to the 3’ end of polyadenylated ...
based inSeattle, WASHINGTON (USA)
Universal Cells is a Seattle-based company that is producing engineered stem cell lines that can avoid rejection and be used in allogeneic cell therapy treatments for the people who need them. One Cell, Many Therapies. Universal Cells edits genes ...
Universal Cells uses recombinant Adeno-Associated Virus (rAAV)-mediated gene editing to engineer chromosomal genes without the use of genotoxic nucleases. Serotype 3B rAAV vectors efficiently infect pluripotent stem cells and their single-stranded ...
based inSeongnam-si, SOUTH KOREA
LISCure Biosciences Provides Novel Therapeutics to Patients with Refractory Diseases Using the LMT Platform. LISCure is developing the world’s first injectable immuno-oncology program using non-pathogenic microorganisms. We focus on the development ...
The LMT (LISCure Microbiology-based Technology) platform is an innovative tool to keep discovering and analyzing microbial and genome-based drug candidates. LMT (LISCure Microbiology-based Technology) Platform Consists of the Therapeutic Screening ...
based inPalo Alto, CALIFORNIA (USA)
Lucence is a precision oncology company committed to bringing clarity to cancer care. Lucence makes ultrasensitive non-invasive liquid biopsy tests to provide doctors and their patients life-changing information to enable earlier detection and ...
Tissue500™ is a comprehensive genomic profiling test that detects clinically relevant mutations in 572 genes to identify a patient’s unique cancer ...
based inBoston, MASSACHUSETTS (USA)
SOPHiA GENETICS is the creator of a global data-sharing network – we work with customers from over 790 institutions in over 70 countries. Our network advances data-driven medicine to improve health outcomes and economics worldwide. We offer a ...
Next-generation sequencing (NGS) has the potential to revolutionize the diagnosis and treatment of cancers and rare diseases but creates extremely large, complex, and noisy datasets for analysis. Without the right analytical technology, ...
based inDaejeon, SOUTH KOREA
We are exploring sequence-based drug discovery and development, which is bypassing the need for 3D structure. ...
UG is an AI platform for developing new drugs that is based on DEARGEN’s deep learning technology. It specializes in genome data analysis, biomarker prediction, molecule selection and optimization. DEARGEN ...
based inBoston, MASSACHUSETTS (USA)
Genomic data is becoming increasingly important in modern healthcare as well as in biological research. The size and complexity of this data, however, makes it almost impossible for many experts to get the most out of this data. Frameshift Genomics ...
based inKöln, GERMANY
Singleron Biotechnologies is an innovative molecular diagnostic company dedicated to applying groundbreaking single cell analysis techniques in clinical diagnosis, drug development, and health management. Singleron Biotechnologies is an innovative ...
based inSeoul, SOUTH KOREA
We detect and analyze genomic profile of tumor DNA with a single draw of blood. With this comprehensive profile, we provide personalized and optimized analysis information that can be utilized in therapy selection and monitoring. Ultimately, we ...
based inEl Segundo, CALIFORNIA (USA)
BioDiscovery has been an established leader in genomic bioinformatics for more than 23 years with a mission of improving patient care through effective use of genomic data. Our platform agnostic approach allows customers to use data from any ...
Arming researchers with advanced genomic data analysis and visualization tools. Easy-to-use software provides cutting-edge statistical tools to advance scientific ...
based inZürich, SWITZERLAND
BC Platforms is a global leader in providing a powerful data and technology platform for personalized medicine and drug development, accelerating the translation of insights into clinical practice. Our technology drives the infinite loop between ...
BC | INSIGHT is a data and research management solution for clinical genomics studies. Genomic and phenotypic data is collected and stored on the platform, and users have access to data and tools through an ...